New Publications

Choroidal Hemangioma

Notre Dame Honorary Degree Bestowed on Dr. Shields

View All Recent Publications

Eyes in the News

Young Golfer Who Beat Cancer Gives Back

A New Approach to Treating Rare Eye Cancer in Children

Chemosurgery goes directly to tumor

Shields Around the World

  • India India Jerry Shields, MD gave two named lectures; 1 for the Vitreo Retinal Society of India in the City of Mysore and another one for The Prasid Eye Institute in the City of Hyderabad.
  • China China Ralph Eagle, MD, Carol Shields, MD and Jerry Shields, MD attended the 25th APAO Congress - a joint meeting of Asia-Pacific Academy of Ophthalmology and The American Academy of Ophthalmology. Dr. Jerry Shields gave the annual keynote lecture.
  • Pittsburgh Pittsburgh Dr. Carol Shields was honored by the University of Pittsburgh Medical Center and received the distinguished Albert C. Muse Prize for her many contributions in the field of Ocular Oncology.

More Information

Ocular Oncology Office

Research

Funding

Contributions

Pearls for Patients

Financial Support

References

Sitemap

Sponsored Websites

Through Kyle's Eyes Foundation™

Ocular Oncology Websites

malignantmelanomainfo.com

retinoblastomainfo.com

eyecancerinfo.com

eyecancerbook.com

etrf.org

SolidWebsiteS.com

Website created and managed by SolidWebsiteS.com



Sara E. Lally is a graduate of Jefferson Medical College. Board certified in ophthalmology, she completed her residency at Geisinger Medical Center in Danville, PA.  Dr. Lally also completed a two year clinical fellowship in Ocular Oncology at Wills Eye Institute.  Her clinical interests include tumors of the conjunctiva, the eyelid, and the orbit. She is also involved in research investigating new treatments for the complications of radiation on the eye and is experienced with coated hydroxyapatite implants after enucleation.  She is a Clinical Instructor at Thomas Jefferon University and is active with professional societies including the American Academy of Ophthalmology and International Society of Ocular Oncology.

Back to Staff